Aflibercept Not for Prevention in Early Diabetic Retinopathy

'Preventive treatment with anti-VEGF [such as aflibercept] for eyes with nonproliferative diabetic retinopathy generally is not a strategy that is warranted,' says study investigator.
Medscape Medical News

Full Story →